Gallotta Valerio, Chiantera Vito, Conte Carmine, Vizzielli Giuseppe, Fagotti Anna, Nero Camilla, Costantini Barbara, Lucidi Alessandro, Cicero Carla, Scambia Giovanni, Ferrandina Gabriella
Division of Gynecologic Oncology, Catholic University of the Sacred Heart, Rome, Italy.
Department of Obstetrics and Gynecology, University Hospital "Paolo Giaccone", Palermo, Italy.
J Minim Invasive Gynecol. 2017 Jan 1;24(1):133-139. doi: 10.1016/j.jmig.2016.09.005. Epub 2016 Sep 22.
To assess the feasibility of total robotic radical surgery (TRRS) in patients with locally advanced cervical cancer (LACC) who receive chemoradiation therapy (CT/RT).
A prospective (preplanned) study of a nonrandomized controlled trial (Canadian Task Force classification level 2).
Catholic University of the Sacred Hearth, Rome, Italy.
Between September 2013 and January 2016, a total of 40 patients with LACC (Fédération Internationale de Gynécologie et d'Obstétrique stage IB2-III) were enrolled in the study.
Robotic radical hysterectomy (RRH) plus pelvic and/or aortic lymphadenectomy was attempted within 6 weeks after CT/RT. The feasibility of TRRS as well as the rate, pattern, and severity of early and late postoperative complications were analyzed.
After CT/RT, 29 patients (72.5%) underwent type B2 RRH, and 11 (27.5%) underwent type C1 RRH. Pelvic lymphadenectomy was performed in all cases. TRRS was successful in 39 of 40 cases (feasibility rate = 97.5%). In patients successfully completing TRRS, the median operating time was 185 minutes (range, 100-330 minutes), and the median blood loss was 100 mL (range, 50-300 mL). The median time of hospitalization counted from the first postoperative day was 2 days (range, 1-4 days). No intraoperative complications were recorded. During the observation period (median = 18 months; range, 4-28 months), 9 of 40 (22.5%) experienced postoperative complications, for a total number of 12 complications. As of April 2016, recurrence of disease was documented in 5 cases (12.5%).
TRRS is feasible in LACC patients administered preoperative CT/RT, providing perioperative outcomes comparable with those registered in early-stage disease, and LACC patients receiving neoadjuvant chemotherapy.
评估全机器人根治性手术(TRRS)在接受放化疗(CT/RT)的局部晚期宫颈癌(LACC)患者中的可行性。
一项前瞻性(预先规划)的非随机对照试验研究(加拿大工作组分类级别2)。
意大利罗马圣心天主教大学。
2013年9月至2016年1月期间,共有40例LACC患者(国际妇产科联盟分期IB2 - III期)纳入本研究。
在CT/RT后6周内尝试进行机器人根治性子宫切除术(RRH)加盆腔和/或主动脉旁淋巴结清扫术。分析TRRS的可行性以及术后早期和晚期并发症的发生率、类型和严重程度。
CT/RT后,29例患者(72.5%)接受了B2型RRH,11例(27.5%)接受了C1型RRH。所有病例均进行了盆腔淋巴结清扫术。40例患者中有39例TRRS成功(可行性率 = 97.5%)。成功完成TRRS的患者,中位手术时间为185分钟(范围100 - 330分钟),中位失血量为100毫升(范围50 - 300毫升)。从术后第一天起计算的中位住院时间为2天(范围1 - 4天)。未记录术中并发症。在观察期(中位时间 = 18个月;范围4 - 28个月)内,40例患者中有9例(22.5%)出现术后并发症,共12例并发症。截至2016年4月,有5例(12.5%)记录到疾病复发。
TRRS在接受术前CT/RT的LACC患者中是可行的,其围手术期结果与早期疾病患者以及接受新辅助化疗的LACC患者相当。